• Journal of KIISE:Software and Applications
• /
• v.36 no.11
• /
• pp.875-890
• /
• 2009

Metabolimics interprets an organism as a network of functional units and an organism is represented by a metabolic pathway i.e., well-displayed graph. So a software tool for drawing pathway is necessary to understand it comprehensively. These tools have a problem that edge-crossings exponentially increase as the number of nodes grows. To apply automatic graph layout techniques to the genome-scale metabolic flow, it is very important to reduce unnecessary edge-crossing on a metabolic pathway layout. In this paper, we design and implement 2.5D metabolic pathway layout modules. Metabolic pathways are represented hierarchically by making use of the '2-layered layout algorithm' in 3D. It enhances the readability and reduces unnecessary edge-crossings by using 3D layout modules instead of 2D layout algorithms.

• Biomaterials and Biomechanics in Bioengineering
• /
• v.2 no.2
• /
• pp.85-96
• /
• 2015

This study developed biodegradable bi-layered drug-eluting beads and investigated the in-vitro release of fluorouracil and cisplatin from the beads. To manufacture the drug-eluting beads, poly[(d,l)-lactide-co-glycolide] (PLGA) with lactide:glycolide ratios of 50:50 and 75:25 were mixed with fluorouracil or cisplatin. The mixture was compressed and sintered at $55^{\circ}C$ to form bi-layered beads. An elution method was employed to characterize the release characteristic of the pharmaceuticals over a 30-day period at $37^{\circ}C$. The influence of polymer type (i.e., 50:50 or 75:25 PLGA) and layer layout on the release characteristics was investigated. The experiment suggested that biodegradable beads released high concentrations of fluorouracil and cisplatin for more than 30 days. The 75:25 PLGA released the pharmaceuticals at a slower rate than the 50:50 PLGA. In addition, the bi-layered structure reduced the release rate of drugs from the core layer of the beads. By adopting the compression sintering technique, we will be able to manufacture biodegradable beads for long-term drug delivery of various anti-cancer pharmaceuticals.